Keyphrases
Body Mass Index
100%
Cardiovascular Events
100%
Intensive Blood Pressure
100%
Blood Pressure Management
100%
Systolic Blood Pressure Intervention Trial (SPRINT)
100%
Intensive Blood Pressure Lowering
37%
Serious Adverse Events
25%
Efficacy Endpoint
25%
Primary Safety
25%
Safety Endpoints
25%
High Risk
12%
All-cause Mortality
12%
Older Adults
12%
Treatment Group
12%
Systolic Blood Pressure
12%
Acute Coronary Syndrome
12%
Cardiovascular Mortality
12%
Without Diabetes
12%
Heart Failure Death
12%
Antihypertensive Treatment
12%
High Cardiovascular Risk
12%
J-shaped Association
12%
Type 1 Diabetes Mellitus (T1DM)
12%
Clinical Outcomes
12%
Medicine and Dentistry
Cardiovascular System
100%
Body Mass Index
100%
Blood Pressure
100%
Systolic Blood Pressure
100%
Intervention Trial
100%
Adverse Event
25%
Apoplexy
25%
All Cause Mortality
12%
Group Therapy
12%
Diabetes Mellitus
12%
Heart Failure
12%
Acute Coronary Syndrome
12%
Cardiovascular Risk
12%
Antihypertensive Therapy
12%
Nursing and Health Professions
Body Mass
100%
Blood Pressure
100%
Systolic Blood Pressure
100%
Adverse Event
25%
Group Therapy
12%
Diabetes Mellitus
12%
Clinical Outcome
12%
Acute Coronary Syndrome
12%
All Cause Mortality
12%
Heart Failure
12%
Cardiovascular Risk
12%
Antihypertensive Therapy
12%
Biochemistry, Genetics and Molecular Biology
Systolic Blood Pressure
100%
Blood Pressure
100%
Intervention Trial
100%
Body Mass
100%
All Cause Mortality
12%
Pharmacology, Toxicology and Pharmaceutical Science
Intervention Trial
100%
Adverse Event
66%
Antihypertensive Agent
33%
All Cause Mortality
33%
Diabetes Mellitus
33%
Heart Failure
33%
Acute Coronary Syndrome
33%
Cardiovascular Risk
33%